BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 4797128)

  • 1. [Treatment of acute leukemia with 2,2'-anhydro-1-beta-D-arabinofuranosylcytosine hydrochloride (cyclocytidine) (author's transl)].
    Masaoka T; Hasegawa Y; Tatsumi N; Nakamura H; Yoshitake J
    Rinsho Ketsueki; 1973 Aug; 14(8):877-81. PubMed ID: 4797128
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of acute leukemia with newly synthesized N4-behenoyl-l-beta-D-arabinofuranosylcytosine (BH-AC) (author's transl)].
    Sueyama H; Oguro M; Takagi T
    Rinsho Ketsueki; 1981 Jul; 22(7):1109-15. PubMed ID: 7328768
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chemotherapy of acute leukemia with cyclocytidine, with special reference to serum ara-C deaminase activity (author's transl)].
    Nakamura T; Sasada M; Sawada H; Higuchi T; Tatsumi K
    Nihon Ketsueki Gakkai Zasshi; 1977 Jun; 40(3):293-9. PubMed ID: 72473
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anhydro-arabinosylcytosine (cyclocytidine) in the therapy of acute leukemia].
    Makino T; Araki K; Inomata K; Kitajima K; Maeda K
    Rinsho Ketsueki; 1974 Dec; 15(12):1346-52. PubMed ID: 4478192
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of acute leukemia].
    Barry A; Delage JM
    Union Med Can; 1970 Jun; 99(6):1045-54. PubMed ID: 5280031
    [No Abstract]   [Full Text] [Related]  

  • 6. [ACNP therapy for DCMP-resistant acute leukemia (author's transl)].
    Naoe T; Hiraiwa A; Akao Y; Tahara T; Yoshikawa H; Yoshikawa S; Naito K; Yamaguchi H
    Rinsho Ketsueki; 1981 Oct; 22(10):1538-44. PubMed ID: 6460886
    [No Abstract]   [Full Text] [Related]  

  • 7. [Análisis de los resultados en veintitrés casos. (COAP therapy for acute grAnulocytic leukaemia. An assay of the results in 25 cases.) (author's transl)].
    Gil JL; Giralt M; Raichs A
    Sangre (Barc); 1975; 20(4):406-14. PubMed ID: 1062010
    [No Abstract]   [Full Text] [Related]  

  • 8. A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.
    Early AP; Preisler HD; Slocum H; Rustum YM
    Cancer Res; 1982 Apr; 42(4):1587-94. PubMed ID: 6949642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [DCTP and DCMP two step therapy in acute non-lymphocytic leukemia (author's transl)].
    Morishima Y; Yamada K; Kawashima K; Ohno R; Ezaki K; Kodera Y; Kobayashi M; Takeyama H; Kato Y; Watanabe E; Suzuki H; Yamaguchi H; Tanimoto M; Minami S; Yokomaku S; Ogura M; Morishita T; Nishiwaki H; Yamada H; Ohara K; Yoshikawa S
    Rinsho Ketsueki; 1980 Jan; 21(1):33-8. PubMed ID: 7373867
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase III study of N4-behenoyl-l-beta-D-arabinofuranosylcytosine in adult acute leukemia-BH-AC-DMP therapy.
    Yamada K; Suzuki H; Kato Y
    Nihon Ketsueki Gakkai Zasshi; 1980 Dec; 43(6):1080-5. PubMed ID: 7331685
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chromosome aberrations of acute leukemia patients in pre- and post-treatment (author's transl)].
    Kamada N; Oguma N; Mikami M; Tanaka R; Ishii Y
    Rinsho Ketsueki; 1975 May; 16(5):505-12. PubMed ID: 1172049
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination chemotherapy with amsacrine (AMSA) and cyclocytidine in refractory childhood leukemia: preliminary observations of a phase II study.
    Miller LP; Miller DR; Tan CT
    Cancer Treat Rep; 1983 May; 67(5):439-43. PubMed ID: 6189604
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of acute leukemia].
    Rynskaia LM
    Probl Gematol Pereliv Krovi; 1971 Jul; 16(7):3-9. PubMed ID: 5124637
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chemotherapy of acute leukemia].
    Nakamura T; Ueda T
    Rinsho Byori; 1984 Sep; 32(9):967-74. PubMed ID: 6394825
    [No Abstract]   [Full Text] [Related]  

  • 15. Antitumor activity of cyclocytidine derivatives.
    Hoshi A; Kanazawa F; Kuretani K; Kanai T; Kikugawa K
    Gan; 1973 Oct; 64(5):519-22. PubMed ID: 4769741
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic experience in acute infantile leukosis].
    Bottone E; Macchia PA; Saggese G
    Minerva Pediatr; 1974 Apr; 26(13):669-77. PubMed ID: 4456201
    [No Abstract]   [Full Text] [Related]  

  • 17. Remission-induction, consolidation and maintenance therapy by AVA protocol in acute nonlymphoblastic leukemia.
    Torlontano G; Geraci L; Lombardo M; Di Marzio A; Iacone A; Fioritoni G; Bonanni G; Di Bartolomeo P; Ballone E; D'Antonio D; Di Girolamo G; D'Arcangelo L; Pandoli G; Natale D; Spadano A
    Haematologica; 1982 Apr; 67(2):230-45. PubMed ID: 6807770
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase I--II study of N4-behenoyl-1-beta-D-arabinofuranosylcytosine.
    Kimura K; Yamada K; Uzuka Y; Maekawa T; Takaku F; Shimoyama M; Ogawa M; Amaki I; Osamura S; Ito M; Sakai Y; Oguro M; Hattori K; Hoshino A; Hirota Y; Ohta K; Nakamura T; Masaoka T; Kimura I; Ichimaru M
    Recent Results Cancer Res; 1981; 76():232-40. PubMed ID: 7232852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The induction chemotherapy of acute leukemia with a new antileukemic agent "neocarzinostatin" (author's transl)].
    Nagao T; Kamimura O; Takahashi I; Kitajima K; Hiraki K
    Rinsho Ketsueki; 1973 Sep; 14(9):925-30. PubMed ID: 4797130
    [No Abstract]   [Full Text] [Related]  

  • 20. [Varicella infections in children with acute leukemia (author's transl)].
    Hasegawa K; Fujimoto T; Kim PY; Nose K; Ito M; Hiyoshi Y
    Rinsho Ketsueki; 1979 Oct; 20(10):1326-30. PubMed ID: 541841
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.